Neoadjuvant Chemoradiotherapy Plus Sintilimab for MSS, Locally Advanced Rectal Cancer-

Stopped Due to errors in the previously submitted modification, we request to withdraw it and will submit a corrected update shortly.

Conditions

• Rectal Cancer

Interventions

• DRUG: neoadjuvant SCRT followed by Sintilimab plus CAPOX

Sponsor

Sun Yat-sen University